Novartis says "deep regret" over Japan drug trials scandal

Administrator 0 Reuters Health
Print Email

TOKYO (Reuters) - The pharmaceutical head at Swiss firm Novartis AG apologized to the Japanese public for alleged manipulation of data in trials of its best-selling blood pressure drug Diovan, saying an employee had acted inappropriately.


Read Full Article


You can contact us at: